
- Upcoming
- 18/06/2026 11:30 Europe/Brussels
From accelerator-driven production to early clinical use
This webinar will explore the Targeted Alpha Therapy (TAT) workflow, from accelerator-driven production to early clinical use, featuring renowned speakers, Prof Dr Tadashi Watabe from Osaka University, Mrs Clémence Maingueneau, PhD, from Arronax Nantes, and Mr Jean-Michel Geets, IBA Fellow and Domain Principal Expert; and moderated by Mrs Cristiana Gameiro, PhD, IBA Fellow and Domain Expert in radiochemistry.
Speakers
Speakers
Prof Dr Tadashi Watabe, M.D., PhDAssociate Professor at the Department of RadiologyUniversity of Osaka, Japan
Mrs Clémence Maingueneau, PhDRadiochemist and Research EngineerArronax Nantes, France
Mr Jean-Michel GeetsDomain Principal ExpertIBA RadioPharma Solutions- Topics
Astatine-211-based Radiopharmaceuticals: Early Clinical Investigation and Emerging Therapeutic Perspectives
Production workflow on Astatine-211
Cyclone® iKure, the new cyclotron designed for industrial scale production of At-211

